Cargando…

Glioma microenvironment-derived CCL2 recruits regulatory T cells and myeloid-derived suppressor cells

Detalles Bibliográficos
Autores principales:	Chang, Alan L, Miska, Jason, Wainwright, Derek A, Dey, Mahua, Qiao, Jian, Pytel, Peter, Han, Yu, Zhang, Lingjiao, Balyasnikova, Irina V, Ahmed, Atique U, Lesniak, Maciej S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645485/ http://dx.doi.org/10.1186/2051-1426-3-S2-P72

Ejemplares similares

The use of anti-GITR antibody treatment in a murine model of glioblastoma multiforme
por: Miska, Jason, et al.
Publicado: (2015)

Intranasal Oncolytic Virotherapy with CXCR4-Enhanced Stem Cells Extends Survival in Mouse Model of Glioma
por: Dey, Mahua, et al.
Publicado: (2016)

The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment
por: Mi, Yajing, et al.
Publicado: (2020)

Resident stroma-secreted chemokine CCL2 governs myeloid-derived suppressor cells in the tumor microenvironment
por: Oo, May Wathone, et al.
Publicado: (2022)

IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM
por: Zannikou, Markella, et al.
Publicado: (2023)

Myeloid-derived suppressor cells in gliomas
por: Gieryng, Anna, et al.
Publicado: (2016)

Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomas
por: Ulasov, Ilya, et al.
Publicado: (2013)

The microenvironment of DLBCL is characterized by noncanonical macrophages recruited by tumor-derived CCL5
por: Manfroi, Benoît, et al.
Publicado: (2021)

Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment
por: Tian, Xinyu, et al.
Publicado: (2019)

Targeting Tregs in Malignant Brain Cancer: Overcoming IDO
por: Wainwright, Derek A., et al.
Publicado: (2013)

Novel Characterization of Myeloid-Derived Suppressor Cells in Tumor Microenvironment
por: Li, Yanan, et al.
Publicado: (2021)

Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment
por: Gao, Xidan, et al.
Publicado: (2021)

Modulation of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment by Natural Products
por: Calderon, Jhon Jairo, et al.
Publicado: (2023)

Modulating glioma-mediated myeloid-derived suppressor cell development with sulforaphane
por: Kumar, Ravi, et al.
Publicado: (2017)

Systemic T Cells Immunosuppression of Glioma Stem Cell-Derived Exosomes Is Mediated by Monocytic Myeloid-Derived Suppressor Cells
por: Domenis, Rossana, et al.
Publicado: (2017)

CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function
por: Chun, Eunyoung, et al.
Publicado: (2015)

Roles of HMGB1 in regulating myeloid-derived suppressor cells in the tumor microenvironment
por: Jin, Shuiling, et al.
Publicado: (2020)

Interaction Between microRNAs and Myeloid-Derived Suppressor Cells in Tumor Microenvironment
por: Liang, Lifei, et al.
Publicado: (2022)

Mesenchymal Stem Cells Modified with a Single-Chain Antibody against EGFRvIII Successfully Inhibit the Growth of Human Xenograft Malignant Glioma
por: Balyasnikova, Irina V., et al.
Publicado: (2010)

Role of Neutrophils and Myeloid-Derived Suppressor Cells in Glioma Progression and Treatment Resistance
por: Khan, Sabbir, et al.
Publicado: (2020)

Oncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice
por: Auffinger, Brenda, et al.
Publicado: (2013)

Pseudomonas aeruginosa Airway Infection Recruits and Modulates Neutrophilic Myeloid-Derived Suppressor Cells
por: Öz, Hasan H., et al.
Publicado: (2016)

Understanding the Differentiation, Expansion, Recruitment and Suppressive Activities of Myeloid-Derived Suppressor Cells in Cancers
por: Lim, Hui Xuan, et al.
Publicado: (2020)

HOXC10 Promotes Metastasis in Colorectal Cancer by Recruiting Myeloid-derived Suppressor Cells
por: Yu, Jiao, et al.
Publicado: (2022)

CCL2 produced by pancreatic ductal adenocarcinoma is essential for the accumulation and activation of monocytic myeloid‐derived suppressor cells
por: Gu, Haitao, et al.
Publicado: (2021)

Survival and complications of stereotactic radiosurgery: A systematic review of stereotactic radiosurgery for newly diagnosed and recurrent high-grade gliomas
por: Fetcko, Kaleigh, et al.
Publicado: (2017)

A Comparative Study of Replication-Incompetent and -Competent Adenoviral Therapy-Mediated Immune Response in a Murine Glioma Model
por: Kim, Julius W., et al.
Publicado: (2017)

The effects of dendritic cell-based vaccines in the tumor microenvironment: Impact on myeloid-derived suppressor cells
por: Sánchez-León, María Luisa, et al.
Publicado: (2022)

Myeloid-Derived Suppressor Cells in Immune Microenvironment Promote Progression of Esophagogastric Junction Adenocarcinoma
por: Wang, Ying, et al.
Publicado: (2021)

The immune suppressive tumor microenvironment in multiple myeloma: The contribution of myeloid-derived suppressor cells
por: Giannotta, Claudia, et al.
Publicado: (2023)

ONO-AE3-208 inhibits myeloid derived suppressor cells and glioma growth
por: Kohanbash, Gary, et al.
Publicado: (2014)

Charachterization and functional analysis of scFv-based CARs to redirect T cells to IL13Rα2-positive glioma
por: Krenciute, Giedre, et al.
Publicado: (2015)

Periodontal inflammation recruits distant metastatic breast cancer cells by increasing myeloid-derived suppressor cells
por: Cheng, Ran, et al.
Publicado: (2019)

Myeloid-Derived Suppressor Cells Alleviate Renal Fibrosis Progression via Regulation of CCL5-CCR5 Axis
por: Qiu, Yue, et al.
Publicado: (2021)

Oncogenic mTOR signaling recruits myeloid-derived suppressor cells to promote tumor initiation
por: Welte, Thomas, et al.
Publicado: (2016)

Chemotherapy-induced recruitment of myeloid-derived suppressor cells abrogates efficacy of immune checkpoint blockade
por: Kwong, Tsz Tung, et al.
Publicado: (2020)

BATF2 prevents glioblastoma multiforme progression by inhibiting recruitment of myeloid-derived suppressor cells
por: Zhang, Xin, et al.
Publicado: (2021)

Ménage à trois: Sustained therapeutic anti-tumor immunity requires multiple partners in malignant glioma
por: Wainwright, Derek A, et al.
Publicado: (2014)

Temozolomide Treatment Increases Fatty Acid Uptake in Glioblastoma Stem Cells
por: Caragher, Seamus, et al.
Publicado: (2020)

Neural Stem Cell Carriers for the Treatment of Glioblastoma Multiforme
por: Miska, Jason, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_q3fnga2o3vhkaenjgluelpqric